- CureVac collaborates with Yale for mRNA-based pulmonary therapeutics
- Sun Pharma to develop more generic products in China
- Clinithink and Healthix harness benefits of AI and massive health data
- BioIVT examines link between HIV Integrase inhibitor drugs and NTD during pregnancy
- China NMPA approves Biktarvy to treat HIV-1 Infection
- Johannesburg gets ready for 5th Healthcare Innovation Summit Africa 2019
- Japanese scientists develop 3D printed prosthetic hand
- Xylonix, Biogemex to co-develop predictive cancer immunotherapy
- Boehringer Ingelheim opens Health Management Centre in China
- V-Wave's Interatrial Shunt receives FDA Breakthrough Device Designation for Heart Failure
- 111, Inc. launches video interview series on China's Healthcare Landscape
- Tasly remains China's 2019 National Tech Innovation Demonstration Enterprise
- Digital Health in India is certainly one of the sunshine sectors:Adrit Raha
- Roche gets approval for oncology drug, Rozlytrek
-
Singapore | 09 July 2019 | News
Asia HealthTech momentum continues unabated closing H1 2019 at $2.5B
Galen Growth Asia, the leading exclusive HealthTech research, analytics and advisory firm in Asia Pac (Asia) s...Read more
Singapore | 04 July 2019 | News
Latest technologies to transform healthcare
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on th...Read more
-
China | 17 August 2019 | News
Sun Pharma to develop more generic products in China
Indian pharma major Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries...Read more
-
World | 17 August 2019 | News
CureVac collaborates with Yale for mRNA-based pulmonary therapeutics
CureVac AG, a fully integrated Germany based biopharmaceutical company pioneering the field of mRNA-based drug...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Stem cells gaining importance
Stem cell research stands as a high-priority field in the Asia-Pacific (APAC) and investment in these facilities are growing in order to increase competitiveness in the free market so that clinical applications can be continually discovered. Stringent regulations in Western Europe and the USA in stem cell therapy and regenerative medicine have driven the APAC to grow at the highest rate in this industry. Stem cell therapy is a hot topic in the field of medicine and is growing at a fast pace, BioSpectrum takes a look at how this exciting field is faring in the APAC region.
